US BANCORP \DE\ - CLEVELAND BIOLABS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$1,0000.0%2,0000.0%0.00%
Q3 2014$1,0000.0%2,0000.0%0.00%
Q2 2014$1,0000.0%2,0000.0%0.00%
Q1 2014$1,000
-50.0%
2,0000.0%0.00%
Q4 2013$2,000
-33.3%
2,0000.0%0.00%
Q3 2013$3,0000.0%2,0000.0%0.00%
Q2 2013$3,0002,0000.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,826,158$1,244,0000.07%
LADENBURG THALMANN FINANCIAL SERVICES INC. 721,200$507,0000.02%
Winfield Associates, Inc. 15,711$11,0000.01%
Van Cleef Asset Management,Inc 20,000$14,0000.01%
ACG Wealth 25,000$17,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$10,0000.00%
OPPENHEIMER & CO INC 25,500$17,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 500$341,0000.00%
BANK OF AMERICA CORP /DE/ 5,390$4,0000.00%
WELLS FARGO & COMPANY/MN 3,000$2,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders